Skip to content

Clinical trials

Phase 1/2 Mouth Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mouth Neoplasms Phase: Phase 1/2 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20091
20102
20121
20131
20171
20181
20191
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status2
Active, not recruiting1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Georgetown University1
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello1
Hope Cancer Institute, Inc.1
Inhibrx Biosciences, Inc1
Klus Pharma Inc.1
Massachusetts General Hospital1
National Cancer Institute (NCI)1
National Institute of Dental and Craniofacial Research (NIDCR)1
Ohio State University Comprehensive Cancer Center1
Sanjiv Sam Gambhir1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mouth Neoplasms15
Oropharyngeal Neoplasms8
Squamous Cell Carcinoma of Head and Neck8
Head and Neck Neoplasms6
Hypopharyngeal Neoplasms6
Laryngeal Neoplasms6
Tongue Neoplasms6
Salivary Gland Neoplasms5
Carcinoma, Squamous Cell4
Nasopharyngeal Neoplasms4

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.